|
Real-time Estimate
Tradegate
03:56:42 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 22.01 EUR | -0.41% |
|
+0.91% | +4.85% |
| 08-17 | Chugai grants GSK exclusive global license for AID351 dengue antibody | AN |
| 08-17 | FTSE 100 drifts lower as oil price pushes higher | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,093B | |||||
| 653B | - | - | - | ||
| 458B | |||||
| 355B | |||||
| 294B |
- Stock Market
- Stocks
- GSK Stock
- GS71 Stock
- Charts GSK plc
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
